Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.
Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. — المؤلف: Sherman, Scott K — JAMA oncology 20191206
- المؤلف
- Sherman, Scott K
- النشر
- JAMA oncology 20191206
- الوصف
- 236-242 p.
- الموضوعات
- Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Bevacizumab؛ Capecitabine؛ Colorectal Neoplasms؛ Cost-Benefit Analysis؛ Disease Progression؛ Drug Costs